Fetch: Over $1 Billion in Rewards
TINA.org investigates advertised milestone.
XanRelax and Addall
Case Name (Date)
Brown et al. v. ZMB Enterprises LLC
22-cv-54, S.D. Cal.
(Jan. 2022)
Product/Service
XanRelax and Addall
Allegations
Misleadingly labeling products as “dietary supplements” when they contain illegal ingredients and thus do not meet the definition of “dietary supplement” under federal law
Misleadingly using the name XanRelax to make consumers believe the product provides benefits similar to the prescription drug Xanax
Misleadingly using the name Addall to make consumers believe the product provides benefits similar to the prescription drug Adderall
Falsely marketing products as able to treat, cure, and prevent diseases, including depression, anxiety, and ADHD, and without FDA approval to do so
Status
Pending
The Latest
Don’t Let a Job Training Offer TRAP You
What consumers should know about a provision hidden in some employment contracts.
Domino’s Free Emergency Pizza
Getting a slice of this complimentary pie may be harder than you think.
How Investing in the Cutting Edge Can Bleed You Dry
What consumers should know about software tethering.
Subway’s Steak and Cheese Sandwiches
Chain faces lawsuit over meat filling representations.